Diagnostic Arrays for Epigenetic Markers

Jones, P.A. and S.B. Baylin (2002). “The Fundamental Role of Epigenetic Events in Cancer.” Nature Rev Genet 3: 415—28.

Shi, H. , S.H. Wei , Y.W. Leu , F. Rahmatpanah , J.C. Liu , P.S. Yan , K.P. Nephew , and T.H.M. Huang (2003). “Triple Analysis of the Cancer Epigenome: An Integrated Microarray System for Analyzing Gene Expression, DNA Methylation, and Histone Acetylation.” Cancer Res 63: 2164—71.

Wei, S.H. , C.M. Chen , G. Strathdee , J. Harnsomburana , C.R. Shyu , F. Rahmatpanah , H. Shi , S.W. Ng , P.S. Yan , K.P. Nephew , R. Brown , and T.H.M. Huang (2002). “Methylation Microarray Analysis of Late-Stage Ovarian Carcinomas Distinguishes Progression-Free Survival in Patients and Identifies Candidate Epigenetic Markers.” Clin Cancer Res 8: 2246— 52.

Yan, P.S. , C.M. Chen , H. Shi , F. Rahmatpanah , S.H. Wei , C.W. Caldwell , and T.H.M. Huang (2001). “Dissecting Complex Epigenetic Alterations in Breast Cancer Using CpG Island Microarrays.” Cancer Res 61: 8375—80.